GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
We'll discuss your goals, review your medical history and any recent labs, evaluate appropriateness, and design a treatment plan with honest pricing
Products applied to the skin do not meet this definition
Global healthcare firm Novo Nordisk, which makes Ozempic, told CNA it is unable to confirm whether product listings on third-party platforms are legitimate, as it only distributes to authorised sellers and not through online marketplaces
However, more studies are needed to fully understand these differences and their implications for weight loss strategies
Either option works